Fiscal first-quarter net earnings were up 23% at $95 million, or $0.41 per share. Total sales increased 12% to $1.50 billion (taking out the benefits of foreign currency translation, sales were up 9%).
Sales of skin care products, which proved a hot sector over recent history, increased 13%, but makeup sales really showed promise, with a 23% boost. Net sales in the Americas increased a mere 4%, but cash registers were ringing in Europe, the Middle East, and Africa, with a 29% increase.
It's a Foolish must for companies to include cash flow information with their earnings, and Estee Lauder did so. In fact, it booked a huge, 1,300% increase in free cash flow compared with the first quarter last year. Although its cash pile dipped by 20% and short-term debt increased by a long shot, the company pared down its long-term debt by 43% to $472.6 million. The company forecasts that it will increase its sales by 7% to 8% in fiscal 2005, with gross margins improving.
It's not hard to see why one might consider Estee Lauder a bellwether of the industry. Its stable of brands includes such favorites as Clinique, Prescriptives, Bobbi Brown, MAC, and Aveda, to name just a few. Although Estee Lauder has plenty of competitors that occupy a variety of niches, such as Avon Products
With a forward P/E ratio of 22 (which is in fact comparable to that of its rival Avon), one might wonder whether Estee Lauder represents a bargain. Given its formidable product line, promising attributes in its earnings, and its enthusiastic eye towards future growth, it seems Estee Lauder might bear a closer look.
Estee Lauder announced that it's raising its dividend. If you're looking for dividend-paying stocks that deliver growth, consider a free trial to Motley Fool Income Investor .
Alyce Lomax does not own shares of any of the companies mentioned.